在线炼干预在改善初级保健中低于值抑郁症患者的抑郁症状的有效性:随机对照试验的协议
Ken O T Yu1, Eric K P Lee1, Benjamin H K Yip1
1JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
BMC psychiatry
|April 9, 2025
概括
这项研究调查了在线炼计划是否可以减少初级保健患者的低值抑郁症症状. 研究结果将指导临床实践和公共卫生政策,以预防抑郁症.
科学领域:
- 初级护理研究初级护理研究
- 心理健康干预措施 心理健康干预
- 运动科学运动科学
背景情况:
- 低于值的抑郁症在初级保健中很普遍,导致医疗保健负担很大.
- 虽然运动有助于诊断抑郁症,但其在初级保健中治疗下值抑郁症的疗效尚未得到充分研究.
- 这项研究解决了对早期抑郁症状的基于证据的干预措施的需求.
研究的目的:
- 为了评估12周在线,导师主导的炼干预措施在初级保健患者中减轻抑郁症状的有效性.
- 将在线运动干预与随机对照试验环境中的常规护理进行比较.
主要方法:
- 一个1:1随机对照试验,涉及260名被诊断患有下值抑郁症的参与者.
- 参与者被分配到在线运动干预 (每周两次为1小时的课程,持续12周) 或常规护理对照组.
- 在基线,干预后以及3个月和9个月的随访期间,使用贝克抑郁 inventory-II (BDI-II) 的中文版本来评估抑郁症状.
主要成果:
- 主要结局:12周后抑郁症状的变化 (BDI-II得分).
- 二次结果:焦虑症状,生活质量,体育活动,可行性,可接受性,药物使用,医疗保健利用率和成本效益.
- 将使用治疗意图分析来评估干预的有效性.
结论:
- 这项研究将确定在线炼计划是否可以有效地改善初级保健环境中的下值抑郁症状.
- 预计结果将为临床医生和政策制定者提供抑郁症预防策略的信息,并可能影响临床指南和公共卫生政策.
更多相关视频
00:07Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
9.6K
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.2K
相关概念视频
Electroconvulsive Therapy
19
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
19
Antidepressant Drugs: MAOIs and Other Agents
170
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
170
